Lyophilization Services of New England is a world-leading Contract Development and Manufacturing Organization (CDMO) that specializes in accelerating the development and commercialization of drug products. With a comprehensive range of pharmaceutical services, they drive development, connect commercialization, and provide integrated speed solutions that simplify the supply chain from study to launch.
With a global presence and a team of over 4,300 professionals across 30 GMP facilities in North America, Europe, and Asia Pacific, Lyophilization Services of New England is committed to bridging the gap between life-changing therapies and patients. Their expertise in sterile development and manufacturing, advanced drug delivery, clinical trial services, and commercial packaging makes them a trusted partner in the pharmaceutical industry.
Generated from the website